Wordt geladen...
The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy. To treat the disease successfully, new therapeutic strategies are urgently needed. One of these strategies can be the use of neurokinin-1 receptor (NK-1R) antagonists (e.g., aprepitant), because the substance P (SP)/NK-1R syst...
Bewaard in:
| Gepubliceerd in: | J Clin Med |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7355887/ https://ncbi.nlm.nih.gov/pubmed/32492831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061659 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|